![Amazon Closes One Medical Acquisition but FTC Intervention Looms](https://www.g2intelligence.com/wp-content/uploads/2023/02/March23.LIR_.MandA-iStock-1800x1250-1-1080x675.jpg)
Amazon Closes One Medical Acquisition but FTC Intervention Looms
The deal closed Feb.22, but the FTC has expressed concerns about the acquisition and Amazon’s business practices in general.
The deal closed Feb.22, but the FTC has expressed concerns about the acquisition and Amazon’s business practices in general.
With COVID-19 testing demand all but dried up, labs will have to make—or at least contemplate making—significant changes to their business.
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Drying COVID-19 testing demand drove revenues down, but not as much as expected.
A code of conduct for sales and marketing staff is essential to allow staff to do their jobs while avoiding liability risk.
How to explain the current state of EKRA to your lab executives.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.